Gut-liver changes drive foodborne infection severity in fatty liver disease
A research team led by the University of California, Irvine’s Joe C. Wen School of Population & Public…
Ultrasound advances offer noninvasive assessment of portal hypertension severity
Portal hypertension (PH), a serious complication of liver cirrhosis, is defined as a pressure gradient > 5 mmHg…
Machine learning model predicts liver cancer risk with high accuracy
Bottom line: A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test…
Palmatine improved fatty liver markers in a preclinical type 2 diabetes study
A new preclinical study suggests that palmatine may ease diabetes-linked fatty liver disease by targeting inflammation, oxidative stress,…
EVA1A regulates fatty acid transporter CD36 in fatty liver disease
Metabolic Dysfunction-Associated Steatotic Liver Disease（MASLD） is characterized by excessive accumulation of lipids in hepatocytes and is closely associated…
New fragmentome technology can detect early liver fibrosis and cirrhosis
Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test using genome-wide cell-free…
New pathway found connecting liver congestion to fibrosis and cancer
Researchers from The University of Osaka find that chronic liver congestion is linked to severe liver diseases through…
Predictive power of C-reactive protein shifts based on cirrhosis or coronary disease
A new study reveals that the predictive power of key inflammatory markers, such as C-reactive protein, shifts fundamentally…
Bacterial infections in patients with liver cirrhosis show rising prevalence and high mortality
Background and aims Bacterial infections (BIs) are common and severe complications in patients with liver cirrhosis, but global…
New study identifies the optimal exercise dose for reducing hepatic steatosis
Hepatic steatosis is a core pathological feature of metabolic dysfunction-associated steatotic liver disease (MASLD). It not only drives…
Blocking platelet-activating factor reduces liver damage in cirrhosis
Researchers from Miguel Hernández University of Elche (UMH) in Spain have identified an effective strategy to reduce structural…
Lab-grown organoid offers a platform to study how liver scarring develops
As chronic liver disease becomes more widespread, researchers at Science Tokyo have developed a lab-grown organoid that replicates…